FDJ Acquires 1.12% Stake in Kindred from Veralda Ahead of Tender Offer

La Française des Jeux (FDJ) Acquires Kindred Group plc

October 23, 2024

Media & Entertainment

La Française des Jeux (FDJ) successfully completed a public tender offer for Kindred Group plc, acquiring at least 98.60% of the company’s share capital and initiating a squeeze-out to buy remaining shares. The acquisition brings Kindred’s digital gaming and betting capabilities into FDJ, significantly expanding FDJ’s international footprint and online revenue mix to create a larger European gaming champion.

FDJ (La Française des Jeux) Acquires Aleda

November 17, 2022

Payments & Fintech

La Française des Jeux (FDJ) has completed the acquisition of Aleda, a France-based provider of point-of-sale (PoS) systems and payment/processing solutions. The transaction closed following conditional approval from the French Competition Authority on November 14, 2022, and strengthens FDJ’s control of its retail distribution and payment processing capabilities.

Vivendi Acquires Amber Capital's Stake in Lagardère

December 16, 2021

Media & Entertainment

Vivendi acquired 24,685,108 Lagardère shares from Amber Capital at €24.10 per share, taking its stake to roughly 45.1% (45.13% reported) and announced it will file a public tender offer for all remaining Lagardère shares at the same price. The transaction (and the planned tender offer) is positioned as a move to obtain control of Lagardère subject to regulatory approvals; Amber Capital remains the selling party.

Humana Acquires Kindred at Home

August 17, 2021

Healthcare Services

Humana Inc. has acquired the remaining 60% interest in Kindred at Home from private equity sponsors TPG Capital and Welsh, Carson, Anderson & Stowe in an $8.1 billion enterprise-value transaction, making Humana the nation’s largest provider of care in the home. Kindred at Home operates home health, hospice and personal care services across ~40 states (serving ~550,000 patients annually and employing ~43,000 caregivers) and will be integrated into Humana’s Home Solutions/CenterWell home health platform to accelerate value-based, home-based clinical care.

Elanco Acquires Kindred Biosciences

June 16, 2021

Biotechnology

Elanco Animal Health acquired all outstanding stock of Kindred Biosciences for $9.25 per share (approximately $440–444 million), strengthening Elanco's biologics and monoclonal antibody R&D capabilities. The deal adds KindredBio's pipeline — including three potential dermatology blockbusters expected through 2025 — and is expected to contribute roughly $100 million to Elanco's innovation revenue outlook by 2025.

CD&R Acquires Majority Stake in Humana's Kindred at Home Hospice and Personal Care Divisions (Gentiva)

April 21, 2022

Healthcare Services

Clayton, Dubilier & Rice (CD&R) agreed to acquire a 60% interest in the Hospice and Personal Care divisions of Humana’s Kindred at Home, receiving approximately $2.8 billion in cash and valuing the divisions at about $3.4 billion. The carved‑out businesses were restructured into a standalone company rebranded as Gentiva, with Humana retaining a 40% minority stake and David Causby continuing as CEO; the deal closed in 2022 and remains subject to customary approvals noted at signing.